Doctor profile · Federal record
Dr. Samuel Myrick, MD
Internal Medicine Physician (CMS: Medical Oncology) · Medical Oncology Physician · Ocala, FL
- NPI 1831180546
- Accepts Medicare
- MIPS 98.1 / 100 · 2023
- 32 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
3130 Sw 32Nd Ave
Ocala, FL 344744445
(352) 732-4032
fax (352) 732-4191
Credentials & registration
- NPI registered
- November 2005 — 21 yrs on file
- Profile last updated
- February 27, 2023
- Year of graduation
- 1994 — 32 yrs since
- Specialty taxonomy
- 207R00000X — NUCC code
- State license (1)
- Florida #ME90579
- Medicaid (2)
- FL #274398100 · GA #522939661A
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1831180546. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
90,343
Distinct HCPCS
10
Medicare allowed
$1,337,636
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
Q5101 |
Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram | 25,560 | 24 | $0 | |
J0881 |
Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 24,090 | 42 | $3 | |
J9271 |
Injection, pembrolizumab, 1 mg | 9,400 | 18 | $54 | |
J1437 |
Injection, ferric derisomaltose, 10 mg | 7,600 | 73 | $21 | |
J0897 |
Injection, denosumab, 1 mg | 5,280 | 45 | $23 | |
J1453 |
Injection, fosaprepitant, 1 mg | 5,100 | 13 | $0 | |
J1568 |
Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | 3,662 | 16 | $42 | |
85025 |
Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 880 | 280 | $8 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 880 | 42 | $0 | |
36415 |
Insertion of needle into vein for collection of blood sample | 841 | 278 | $8 |
In context: peer comparison
Among 27 peers in this city , average services per provider: 422. This provider delivers 214× the peer median.Open Payments
Industry payments received
All-time total
$6,574
Transactions
177
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | 31 | $1,422.84 | |
| PFIZER INC. | 27 | $784.43 | |
| Celgene Corporation | 25 | $394.54 | |
| Astellas Pharma US Inc | 9 | $392.05 | |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $268.21 | |
| Janssen Biotech, Inc. | 17 | $264.46 | |
| AstraZeneca Pharmaceuticals LP | 11 | $226.91 | |
| Genmab U.S., Inc. | 5 | $226.14 | |
| Merck Sharp & Dohme LLC | 8 | $193.13 | |
| E.R. Squibb & Sons, L.L.C. | 8 | $153.49 | |
| Amgen Inc. | 1 | $150.00 | |
| GlaxoSmithKline, LLC. | 6 | $143.26 | |
| Incyte Corporation | 6 | $140.59 | |
| ABBVIE INC. | 8 | $136.04 | |
| GENZYME CORPORATION | 5 | $120.52 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
523
Patients
181
Total drug cost
$492,155
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Anastrozole | Generic | 121 | 37 | $5,617 |
| Dexamethasone | Generic | 44 | 27 | $619 |
| Xarelto (Rivaroxaban) | Brand | 43 | 11 | $36,055 |
| Prednisone | Generic | 39 | 22 | $238 |
| Tamoxifen Citrate | Generic | 33 | 11 | $933 |
| Hydroxyurea | Generic | 29 | 0 | $1,132 |
| Prochlorperazine Maleate | Generic | 27 | 20 | $353 |
| Ondansetron Hcl | Generic | 25 | 20 | $370 |
| Imbruvica (Ibrutinib) | Brand | 24 | 0 | $407,454 |
| Olanzapine | Generic | 24 | 18 | $173 |
Hospital affiliations
Frequently asked questions
What is Dr. Samuel Myrick's medical specialty?
Dr. Samuel Myrick practices Internal Medicine Physician in Ocala, FL.
Where does Dr. Samuel Myrick practice?
Dr. Samuel Myrick practices at 3130 Sw 32Nd Ave, Ocala, FL 344744445. Office phone: 3527324032.
What is Dr. Samuel Myrick's NPI?
Dr. Samuel Myrick's National Provider Identifier (NPI) is 1831180546, issued by NPPES.
Does Dr. Samuel Myrick accept Medicare assignment?
Yes. Dr. Samuel Myrick accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Samuel Myrick commonly perform?
Top Medicare-reported procedures in 2023: Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram (HCPCS Q5101); Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS J0881); Injection, pembrolizumab, 1 mg (HCPCS J9271). Source: CMS Medicare Physician & Other Practitioners file.